187 related articles for article (PubMed ID: 30923325)
21. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
22. On the functions of lithium: the mood stabilizer.
Shastry BS
Bioessays; 1997 Mar; 19(3):199-200. PubMed ID: 9103188
[TBL] [Abstract][Full Text] [Related]
23. The lithium ion: a foundation for psychopharmacological specificity.
Soares JC; Gershon S
Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
[TBL] [Abstract][Full Text] [Related]
24. Lithium response and -116C/G polymorphism of XBP1 in Japanese patients with bipolar disorder.
Kakiuchi C; Kato T
Int J Neuropsychopharmacol; 2005 Dec; 8(4):631-2. PubMed ID: 15836800
[No Abstract] [Full Text] [Related]
25. Pharmacogenetics of lithium response in bipolar disorder.
Alda M
J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
[TBL] [Abstract][Full Text] [Related]
26. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
[TBL] [Abstract][Full Text] [Related]
27. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
28. Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder.
Duffy A; Turecki G; Grof P; Cavazzoni P; Grof E; Joober R; Ahrens B; Berghöfer A; Müller-Oerlinghausen B; Dvoráková M; Libigerová E; Vojtĕchovský M; Zvolský P; Nilsson A; Licht RW; Rasmussen NA; Schou M; Vestergaard P; Holzinger A; Schumann C; Thau K; Robertson C; Rouleau GA; Alda M
J Psychiatry Neurosci; 2000 Sep; 25(4):353-8. PubMed ID: 11022400
[TBL] [Abstract][Full Text] [Related]
29. Mood stabilizers and ion regulation.
El-Mallakh RS; Huff MO
Harv Rev Psychiatry; 2001; 9(1):23-32. PubMed ID: 11159930
[TBL] [Abstract][Full Text] [Related]
30. [Lithium. Principles and rules of use].
Guedj F; Saba G; Olié JP
Rev Prat; 1996 Jun; 46(11):1401-7. PubMed ID: 8794626
[No Abstract] [Full Text] [Related]
31. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
Atack JR; Broughton HB; Pollack SJ
Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
[TBL] [Abstract][Full Text] [Related]
32. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder.
Alda M; Grof P; Rouleau GA; Turecki G; Young LT
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1038-45. PubMed ID: 15946781
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism of circadian clock genes and prophylactic lithium response.
Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
[TBL] [Abstract][Full Text] [Related]
34. Expression of telomerase reverse transcriptase positively correlates with duration of lithium treatment in bipolar disorder.
Lundberg M; Biernacka JM; Lavebratt C; Druliner B; Ryu E; Geske J; Colby C; Boardman L; Frye M; Schalling M
Psychiatry Res; 2020 Apr; 286():112865. PubMed ID: 32114208
[TBL] [Abstract][Full Text] [Related]
35. Is it time to have another look at lithium maintenance therapy in bipolar disorder?
Akhondzadeh S; Emamian ES; Ahmadi-Abhari A; Shabestari O; Dadgarnejad M
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1011-7. PubMed ID: 10621946
[TBL] [Abstract][Full Text] [Related]
36. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.
Kikuchi K; Iga J; Tayoshi S; Nakataki M; Watanabe S; Numata S; Ohmori T
Hum Psychopharmacol; 2011; 26(4-5):358-63. PubMed ID: 21721043
[TBL] [Abstract][Full Text] [Related]
37. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
Lin YF; Huang MC; Liu HC
J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
[TBL] [Abstract][Full Text] [Related]
38. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
[TBL] [Abstract][Full Text] [Related]
39. Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients.
McCarthy MJ; Wei H; Landgraf D; Le Roux MJ; Welsh DK
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1310-9. PubMed ID: 27216486
[TBL] [Abstract][Full Text] [Related]
40. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder.
Hopkins HS; Gelenberg AJ
Bipolar Disord; 2000 Sep; 2(3 Pt 1):174-9. PubMed ID: 11256684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
